The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Open accessAbstract
Rationale: Dysregulation of cellular metabolism has been shown to participate in several pathologic processes. However, the role of metabolic reprogramming is not well appreciated in the pathogenesis of organ fibrosis. Objectives: To determine if glycolytic reprogramming participates in the pathogenesis of lung fibrosis and assess the therapeutic potential of glycolytic inhibition in treating lung fibrosis. Methods: A cell metabolism assay was performed to determine glycolytic flux and mitochondrial respiration. Lactate levels were measured to assess glycolysis in fibroblasts and lungs. Glycolytic inhibition by genetic and pharmacologic approaches was used to demonstrate the critical role of glycolysis in lung fibrosis. Measurements and Main Results: Augmentation of glycolysis is an early and sustained event during myofibroblast differentiation, which is dependent on the increased expression of critical glycolytic enzymes, in particular, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). Augmented glycolysis contributes to the stabilization of hypoxia-inducible factor 1-α, a master regulator of glycolytic enzymes implicated in organ fibrosis, by increasing cellular levels of tricarboxylic acid cycle intermediate succinate in lung myofibroblasts. Inhibition of glycolysis by the PFKFB3 inhibitor 3PO or genomic disruption of the PFKFB3 gene blunted the differentiation of lung fibroblasts into myofibroblasts, and attenuated profibrotic phenotypes in myofibroblasts isolated from the lungs of patients with idiopathic pulmonary fibrosis. Inhibition of glycolysis by 3PO demonstrates therapeutic benefit in bleomycin-induced and transforming growth factor-β1–induced lung fibrosis in mice. Conclusions: Our data support the novel concept of glycolytic reprogramming in the pathogenesis of lung fibrosis and provide proof-of-concept that targeting this pathway may be efficacious in treating fibrotic disorders, such as idiopathic pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, monocytes and macrophages are capable of remarkable functional plasticity, displaying diverse phenotypes during wound healing dependent on multiple cues including the environmental niche61,62 and the temporal stage of tissue injury and repair63–66.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [62]
In the citing paper
“Glycolytic reprogramming has been shown to play an important role in the pathogenesis of lung fibrosis, with higher glycolytic activity detected in fibrotic areas (143).”
From Aging and Lung Disease (2020) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation
Lunt, S. Y., & Vander Heiden, M. G. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154237 · Cited by 3,057
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Self-citation
Research works printed but not linked: 1
- Xie, 2015, Glycolytic reprogramming is required for myofibroblast differentiation and lung fibrosis [abstract], Am J Respir Crit Care Med, 191, A4922
Cited by
Sorted by citations
Items 301–400 of 585
A model of the aged lung epithelium in idiopathic pulmonary fibrosis
Shaghaghi, H., Cuevas-Mora, K., Para, R., Tran, C., Roque, W., Robertson, M. J., Rosas, I. O., Summer, R. S., & Romero, F. (2021) · Aging · doi:10.18632/aging.203291 · Cited by 14
Trivlidis, J., Aloufi, N., Al‐Habeeb, F., Nair, P. K., Azuelos, I., Eidelman, D. H., & Baglole, C. J. (2021) · Respiratory Research · doi:10.1186/s12931-021-01916-4 · Cited by 14
Yang, Q., Zong, X., Zhuang, L., Pan, R., Tudi, X., Fan, Q., & Tao, R. (2023) · Biomolecules · doi:10.3390/biom13071072 · Cited by 14
Shakeel, I., Afzal, M., Islam, A., Sohal, S. S., & Hassan, M. I. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100167 · Cited by 15
Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases
Drzewicka, K., & Zasłona, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328781 · Cited by 14
Role of pH-sensing receptors in colitis
Hausmann, M., Seuwen, K., de Vallière, C., Busch, M., Ruiz, P. A., & Rogler, G. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02943-y · Cited by 15
Hypoxia and Hypoxia-Inducible Factors in Lymphedema
Jiang, X., Tian, W., Kim, D., McQuiston, A. S., Vinh, R., Rockson, S. G., Semenza, G. L., & Nicolls, M. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.851057 · Cited by 16
Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis
Sun, C., Zhu, H., Wang, Y., Han, Y., Zhang, D., Cao, X., Alip, M., Nie, M., Xu, X., Lv, L., et al. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06372-z · Cited by 13
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis
Huang, W., Chuang, C.-F., Huang, Y.-T., Chung, I., Chen, M.-L., Chuang, T., Yang, X., Chou, Y.-Y., Liu, C.-H., Chen, N., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02583-3 · Cited by 15
Sun, J., Zhao, N., Zhang, R., Li, Y., Yu, T., Nong, Q., Lin, L., Yang, X., Luan, T., Chen, B., et al. (2024) · Journal of Environmental Sciences · doi:10.1016/j.jes.2024.02.020 · Cited by 13
Mitochondrial Transplantation Ameliorates Pulmonary Fibrosis by Suppressing Myofibroblast Activation
Lee, S.-E., Yu, S.-H., Kim, I.-H., Kang, Y. C., Kim, Y., Yeo, J. S., Lim, J., Kwon, I., Kim, J.-H., Park, S.-W., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312783 · Cited by 13
Mitochondrial Dysfunction and Morphological Abnormality in Keloid Fibroblasts
Li, Q., Qin, Z., Chen, B., An, Y., Nie, F., Yang, X., Pan, B., & Bi, H. (2019) · Advances in Wound Care · doi:10.1089/wound.2019.0988 · Cited by 13
Dias, H. B., de Oliveira, J. R., Donadio, M. V. F., & Kimura, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222202 · Cited by 13
Wang, L., Zhong, W. H., Liu, D. Y., Shen, H. Q., & He, Z. J. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211060513 · Cited by 13
Pro-fibrotic effects of PFKFB4-mediated glycolytic reprogramming in fibrous dysplasia
Lee, M., Yoo, C. H., Son, M., Kim, Y., Jeon, H., Chang, J. S., & Cho, Y. S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.042 · Cited by 13
Assessment of 18F-FDG uptake in idiopathic pulmonary fibrosis: influence of lung density changes
Castiaux, A., Simaeys, G. V., Goldman, S., & Bondue, B. (2018) · European Journal of Hybrid Imaging · doi:10.1186/s41824-018-0045-z · Cited by 13
Zheng, J., Du, Y., Shao, W., Li, J., Zhao, P., & Zhang, Q. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156628 · Cited by 12
Metabolism and bioenergetics in the pathophysiology of organ fibrosis
Miguel, V., Alcalde‐Estévez, E., Sirera, B., Rodríguez‐Pascual, F., & Lamas, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.001 · Cited by 13
Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
Chattopadhyaya, S., Nagalingam, R. S., Ledingham, D. A., Moffatt, T. L., Al‐Hattab, D. S., Narhan, P., Stecy, M. T., O’Hara, K. A., & Czubryt, M. P. (2022) · Cells · doi:10.3390/cells11091471 · Cited by 12
Oncometabolism: A Paradigm for the Metabolic Remodeling of the Failing Heart
Kuhn, A.-R., & van Bilsen, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213902 · Cited by 13
Soussi, S., Savchenko, L., Rovina, D., Iacovoni, J. S., Gottinger, A., Vialettes, M., Pioner, J. M., Farini, A., Mallia, S., Rabino, M., et al. (2023) · Biology Direct · doi:10.1186/s13062-023-00398-2 · Cited by 14
Dai, T., Liang, Y., Li, X., Zhao, J., Li, G., Li, Q., Xu, L., & Zhao, J. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1608750 · Cited by 11
Ziehr, D. R., Li, F., Parnell, K. M., Krah, N. M., Leahy, K. J., Guillermier, C., Gao, C., Prell, S. A., Vigder, N., Poli, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.ads2673 · Cited by 16
Ghincea, A., Woo, S., Yu, S., Pivarnik, T., Fiorini, V., Herzog, E. L., & Ryu, C. (2023) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-023-00211-1 · Cited by 11
Liang, M., Si, L., Yu, Z. H., Ding, H., Wang, L., Chen, X., Chen, B.-Y., Zhang, J., & Cao, J. (2023) · Sleep And Breathing · doi:10.1007/s11325-023-02889-y · Cited by 11
Zhang, J., Li, H., Zhong, H., Chen, X., & Hu, Z. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111561 · Cited by 11
Circular RNAs and their roles in idiopathic pulmonary fibrosis
Surendran, A. M., Huang, C., & Liu, L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02716-2 · Cited by 13
Primerano, A., Domenico, E. D., Cianfarani, F., Luca, N. D., Floriddia, G., Teson, M., Cristofoletti, C., Cardarelli, S., Scaglione, G. L., Baldini, E., et al. (2024) · British Journal of Dermatology · doi:10.1093/bjd/ljae225 · Cited by 11
A New Target for Hepatic Fibrosis Prevention and Treatment: The Warburg Effect
Pan, M., Li, H. Z., & Shi, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2909321 · Cited by 13
Li, K., Liu, X., Lu, R., Zhao, P., Tian, Y., & Li, J. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117451 · Cited by 11
Wang, L., Zhu, W., Sun, R., Liu, J., Ma, Q., Zhang, B., & Shi, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/7753508 · Cited by 10
Zhang, L., Li, Q., Deng, Y., Zou, Y., Wang, L., & Li, J. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13655 · Cited by 14
Hong, J., Pham, T. X., Lee, J., Raslan, A., Nicolas, K., Sharov, A. A., Meridew, J. A., Urrutia, R. A., Lomberk, G. A., Huang, S. K., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0255oc · Cited by 10
Protein Ubiquitination Modification in Pulmonary Fibrosis
Shen, J., Jiang, Y., Bu, W., Yu, M., Huang, R., Tang, C., Yang, Z., Gao, H., Su, L., Cheng, D., et al. (2025) · Comprehensive physiology · doi:10.1002/cph4.70013 · Cited by 10
Li, Q., Ling, Y., Ma, Y., Zhang, T., Yang, Y., & Tao, S. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.115994 · Cited by 13
Reese‐Petersen, A. L., Nielsen, S. H., Sand, J. M. B., Schattenberg, J. M., Bugianesi, E., & Karsdal, M. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15615 · Cited by 11
In vivo imaging of the progression of acute lung injury using hyperpolarized [1‐13C] pyruvate
Pourfathi, M., Xin, Y., Kadlecek, S. J., Cereda, M. F., Profka, H., Hamedani, H., Siddiqui, S. M., Ruppert, K., Drachman, N., Rajaei, J., et al. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26604 · Cited by 10
HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells
Chen, Y., Bao, T.-T., Jin, L., Lu, J., & Feng, J. (2023) · Journal of Oncology · doi:10.1155/2023/3876342 · Cited by 9
Zhang, T., Mi, J., Qin, X., Ouyang, Z., Wang, Y., Li, Z., He, S., Hu, K., Wang, R., & Huang, W. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s458794 · Cited by 9
Alvarado‐Vásquez, N., Rangel‐Escareño, C., Ramos-Abundis, J. D. J., Becerril, C., & Negrete-García, M. C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117680 · Cited by 10
Gao, H., Sun, Z., Hu, X., Song, W., Liu, Y., Zou, M., Zhu, M., & Cheng, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1486357 · Cited by 9
Yang, H., Lv, D., Li, X., Chen, Y., Xu, H., Wu, H., Wang, Z., Cao, X., Tang, B., Deng, W., et al. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00763-1 · Cited by 10
Li, X., Li, D., Liu, S., Wang, Y., Fan, X., Yan, Z., Tan, S., Zhuang, P., & Zhang, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157529 · Cited by 10
Xu, H., Yang, J., Tu, M., Weng, J., Xie, M., Zhou, Z., Zhou, P., Wang, L., Chen, C., & Wang, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.901000 · Cited by 9
HIF-1α Mediates Arsenic-Induced Metabolic Reprogramming in Lung Bronchial Epithelial Cells
Wang, W., & Zhang, A. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03315-2 · Cited by 9
Rackow, A. R., Nagel, D. J., Zapas, G., Clough, R., Sime, P. J., & Kottmann, R. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911946 · Cited by 9
Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis
Jo, M.-S., Yang, H., Park, J., Shin, J., & Park, I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281640 · Cited by 11
Voisin, T., Joannes, A., Morzadec, C., Lagadic‐Gossmann, D., Naourès, C. L., Latour, B. R. D., Rouzé, S., Jouneau, S., & Vernhet, L. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109558 · Cited by 9
Kikuchi, R., Maeda, Y., Tsuji, T., Yamaguchi, K., Abe, S., Nakamura, H., & Aoshiba, K. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13247 · Cited by 9
Ren, Y., Wang, J., Guo, W., Chen, J., Wu, X., Gu, S., Xu, L., Wu, Z., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.830312 · Cited by 9
Silva, T. D., Alves, C. A., Oliveira, H., & Duarte, I. F. (2022) · Air Quality Atmosphere & Health · doi:10.1007/s11869-022-01236-6 · Cited by 10
Towards a global initiative for fibrosis treatment (GIFT)
Molina‐Molina, M., Agustí, A. G. N., Crestani, B., Schwartz, D. A., Königshoff, M., Chambers, R. C., Maher, T. M., Faner, R., Mora, A. L., Rojas, M. M., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00106-2017 · Cited by 9
Pan, T., Bai, L., Zhu, D., Wei, Y., Zhao, Q., Feng, F., Wang, Z., Xu, Y., & Zhou, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300423 · Cited by 8
Nie, Z.-Q., Wu, J., Xie, J., & Yin, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33314 · Cited by 8
Metabolism and Targeted Therapy of Fibrosis in Chronic Pancreatitis: A Review
Luo, H., Guo, S., Chu, Y., Xin, Y., Yin, X., & Li, X. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.118338 · Cited by 10
Emerging roles of the metabolite succinate in bone-related diseases
Wu, Z., Dai, Q., Wang, Y., Wu, N., Wang, C., & Shi, J. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400406 · Cited by 11
Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET
Kagimoto, A., Tsutani, Y., Handa, Y., Mimae, T., Miyata, Y., & Okada, M. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.08.018 · Cited by 8
Qiaolongbatu, X., Zhao, W., Huang, X., Qian, F., Yang, X., Wu, J., Ma, C., Qu, H., Wang, L., Fan, G., et al. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s391503 · Cited by 8
Liu, F., Chen, Y., Qin, D., & Cheng, Q. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155256 · Cited by 8
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face
Mendoza‐Marí, Y., Fraix, M. P., & Agrawal, D. K. (2024) · Archives of Internal Medicine Research · doi:10.26502/aimr.0165 · Cited by 10
Trujillo, G., Regueiro‐Ren, A., Liu, C., Hu, B., Sun, Y. S., Ahangari, F., Fiorini, V., Ishikawa, G., Jumaily, K. A., Khoury, J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0065oc · Cited by 10
Yakupova, E. I., Zorov, D. B., & Plotnikov, E. Y. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921120099 · Cited by 8
Jeon, K., Kumar, A., Callan, C. L., DeMagistris, M., Macrae, S. M., Nehrke, K. W., & Huxlin, K. R. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.13.36 · Cited by 10
Novel molecular therapeutic targets in cardiac fibrosis: a brief overview
Wang, R., Lin, J. J., & Bagchi, R. A. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0430 · Cited by 8
Collagen Biosynthesis in Pulmonary Fibrosis: Unraveling the Metabolic Web
Bernard, K. F. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0350ed · Cited by 8
Self-citationTavakkoli, M., Khodashahi, R., Aliakbarian, M., Rahimi, H., Ashrafzadeh, K., Ferns, G. A., Khaleghi, E., & Arjmand, M. (2023) · Current Molecular Pharmacology · doi:10.2174/0118761429246636230919122745 · Cited by 7
Search progress of pyruvate kinase M2 (PKM2) in organ fibrosis
Lv, S., Cao, M., Luo, J., Fu, K., & Yuan, W. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09307-w · Cited by 8
Wells, C., Nguyen, D. C., Brainard, R. E., McNally, L. A., Silva, M. D., Brittian, K. R., Garrett, L. T., Taylor, M., Martinez‐Ondaro, Y., Howard, C., et al. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.07.005 · Cited by 7
Wang, L., Jiang, P., Li, J., Huang, Y., Wen, J., Wu, Z., Chen, Y., & Hu, J. (2023) · Journal of Cancer · doi:10.7150/jca.54775 · Cited by 7
Arrestin beta 1 Regulates Alveolar Progenitor Renewal and Lung Fibrosis
Huang, G., Gen, Y., Kulur, V., Liu, N., Liu, X., Taghavifar, F., Liang, J., Noble, P. W., & Jiang, D. (2024) · Journal of Respiratory Biology and Translational Medicine · doi:10.35534/jrbtm.2024.10006 · Cited by 7
Aging-Associated Metabolite Methylmalonic Acid Increases Susceptibility to Pulmonary Fibrosis
Xu, K., Ding, L., Li, W., Wang, Y., Ma, S., Lian, H., Pan, X., Wan, R., Zhao, W., Yang, J., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.011 · Cited by 8
Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis
Masoumi, M., Bodaghi, A., Khorramdelazad, H., Ebadi, E., Houshmandfar, S., Saeedi‐Boroujeni, A., & Karami, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35445 · Cited by 7
Fleckner, M., Döhmen, N. K., Salz, K., Christophers, T., Windolf, J., Suschek, C. V., & Oezel, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313013 · Cited by 7
Xu, Q., He, X., Mou, Y., Sun, D. I., Zhang, X., Han, J., Liu, X., Liu, X., Ren, X., Wang, D., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04121-4 · Cited by 8
Systems medicine advances in interstitial lung disease
Greiffo, F. R., Eickelberg, O., & Fernandez, I. E. (2017) · European Respiratory Review · doi:10.1183/16000617.0021-2017 · Cited by 8
Glycolysis and Autoimmune Diseases: A Growing Relationship
Rezaei, R., Tahmasebi, S., Atashzar, M. R., & Amani, D. (2020) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747820020154 · Cited by 7
Abdelrahman, R. S., & Shawky, N. M. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23071 · Cited by 7
Melatonin modulates metabolic adaptation of pancreatic stellate cells subjected to hypoxia
Estarás, M., Martínez, R., Sánchez, A. G., Ortiz-Placín, C., Iovanna, J., Santofimia‐Castaño, P., & González, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115118 · Cited by 7
Skorupa, A., Ciszek, M., Turska-d’Amico, M., Stobiecka, E., Chmielik, E., Szumniak, R., d’Amico, A., Boguszewicz, Ł., & Sokol, M. B. (2023) · Cancers · doi:10.3390/cancers15041283 · Cited by 8
Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
Shimoji, K., Nakashima, T., Masuda, T., Namba, M., Sakamoto, S., Yamaguchi, K., Horimasu, Y., Mimae, T., Miyamoto, S., Iwamoto, H., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04756-6 · Cited by 7
Go, G., Yoon, Y. M., Yoon, S., Lee, G., Lim, J. H., Han, S.-Y., & Lee, S. H. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.058 · Cited by 7
Mei, S., Tang, R. N., Hu, Y., Feng, J., Xu, Q., Zhou, Y., Zhong, H., Gao, Y., He, Z., & Xing, S. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2022.100021 · Cited by 7
Activated Fibroblasts: Gluttonous for Glutamine
Nieweld, C., & Summer, R. S. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0155ed · Cited by 8
Zhang, X., Sun, J., Guo, J., Hu, X., Zhou, J., Xie, X., Chen, X., Luo, H., Liu, H., & Tian, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02210-2 · Cited by 6
Wang, M., Xie, Y., Cao, Y., Yu, B., & Dai, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593729 · Cited by 6
Castelli, G., Cocconcelli, E., Grimaudo, G., Leo, I. D., Bellani, S., Fiorentù, G., Giulianelli, G., Bernardinello, N., Balestro, E., & Spagnolo, P. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050213 · Cited by 7
Yang, H., Zhang, L., Chen, G., Wu, Q., Li, M., Zhang, C., Han, M., & Xu, Q. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117456 · Cited by 6
Chen, H., Hua, C., Chang, S., Qiu, Y., Lin, X., & Sun, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04651-5 · Cited by 6
Altered Metabolism in Idiopathic Pulmonary Fibrosis
Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70112 · Cited by 6
Beyond a metabolite: lactate and lactylation in lung diseases
Wang, Y., Hiemstra, P. S., Jiang, C., & Song, G. (2026) · Respiratory Research · doi:10.1186/s12931-026-03543-3 · Cited by 6
Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis
Zeng, Y., Huang, J., Guo, R., Cao, S., Yang, H., & Ouyang, W. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1058582 · Cited by 6
Untargeted Metabolomics Reveals Alterations of Rhythmic Pulmonary Metabolism in IPF
Sun, W., Ren, J., Jia, Z., Liang, P., Li, S., Song, M., Cao, Y., Chen, H., Luo, Q., Yang, L., et al. (2023) · Metabolites · doi:10.3390/metabo13101069 · Cited by 6
Freeberg, M. A. T., Thatcher, T. H., Camus, S., Huang, L., Atkinson, J. M., Narrow, W. C., Haak, J., Dylag, A. M., Cowart, L. A., Johnson, T. S., et al. (2024) · Physiological Reports · doi:10.14814/phy2.16012 · Cited by 6
Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis
Whi, W., Lee, H.-H., Cho, Y. S., Lee, H., Yoo, H., Chung, M. P., & Choi, J. Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-83787-5 · Cited by 6
Ye, Z., Li, W., Jiang, Z., Wang, E., & Wang, J. (2021) · iScience · doi:10.1016/j.isci.2021.103057 · Cited by 6
Diagnostic Value of Nodal Staging of Lung Cancer With Usual Interstitial Pneumonia Using PET
Nomura, K., Fukui, M., Hattori, A., Matsunaga, T., Takamochi, K., & Suzuki, K. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.03.056 · Cited by 6
Alveolar Epithelial Cells Burn Fat to Survive Acute Lung Injury
Hamanaka, R. B., & Mutlu, G. M. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0300ed · Cited by 6
Tang, J., Li, T., He, X., Liu, Y.-L., Zhou, M.-L., Wu, M., Li, Y., Lan, Y., Tan, X., Tian, J., et al. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139580 · Cited by 8
Musculoskeletal Diseases: Mechanisms and Therapeutic Advances
Ma, X., Yinwang, E., Chai, X., Wang, F., Chen, Z., Wang, S., Zhou, H., Xue, Y., Lei, J., Chen, F., et al. (2025) · MedComm · doi:10.1002/mco2.70519 · Cited by 7
Li, H., Di, R., & Kong, D. (2026) · Scientific Reports · doi:10.1038/s41598-025-34150-9 · Cited by 5
Metadata
- Authors
- Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Liu, Gang
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-12
- Volume
- 192
- Issue
- 12
- Pages
- 1462-1474
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC4731722
- OpenAlex
- W1793883704
- Cited by
- 582
- References
- 57
- Citations by year
- 2026: 60 · 2025: 67 · 2024: 75 · 2023: 89 · 2022: 63 · 2021: 78 · 2020: 47 · 2019: 34 · 2018: 30 · 2017: 25 · 2016: 10 · 2015: 3
- FWCI
- 17.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 076206, HL114470, HL-105473, R01HL105473, R01HL076206, P01HL114470)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- glycolytic reprogramming, pulmonary fibrosis, myofibroblast differentiation, PFKFB3, 3PO, hypoxia-inducible factor-1α, succinic acid, cellular metabolism, idiopathic pulmonary fibrosis, bleomycin-induced fibrosis, TGF-β1, glycolysis inhibition, fibroblasts
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Disease Models, Animal, Glycolysis, Humans, Lung, Mice, Inbred C57BL, Mice, Idiopathic Pulmonary Fibrosis, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
